The Recall Desk

Recalls

All US Product Recalls

Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.

How to read this listing

Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means deaths or serious injuries are reported, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.

The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.

Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.

Filters

Agency

Category

Minimum severity

Clear filters

26–50 of 8579

  • CriticalFDA (Drugs)·D-0772-2026·2026-08-19

    Victory Medical Center Pharmacy Recalls Glutathione Vials Due to Contamination

    Victory Medical Center Pharmacy is recalling 91 vials of Glutathione (MDV) 200 mg/mL due to bacterial endotoxin contamination.

    Product
    Glutathione (MDV), 200 mg/mL, 30 mL vial, each mL contains Glutathione 200 mg, Ascorbic Acid 20 mg, Benzyl Alcohol 1.5%, Na Hydroxide (Ph Adjust) in sterile water for injection, VMC.
    Category
    Drug
    Distribution
    Distributed nationwide
  • CriticalFDA (Drugs)·D-0773-2026·2026-08-19

    Optiray Injection Recalled for Presence of Particulate Matter

    Liebel-Flarsheim is recalling 3,486 vials of Optiray Injection due to the presence of particulate matter, including plastic, stainless steel, and glass.

    Product
    OPTIRAY — OPTIRAY (IOVERSOL)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0757-2026·2026-08-19

    Apollo Care Recalls Semaglutide Vials Due to Particulate Matter

    Apollo Care, LLC is recalling specific lots of Semaglutide 20mg vials because they contain nylon and silk-type particulate matter.

    Product
    SEMAGLUTIDE 20mg (5mg/mL), Glycine 20 mg (5mg/mL), 4 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-724-04.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0787-2026·2026-08-19

    Baxter Recalls Cefazolin Injection Bags Due to Particulate Matter

    Baxter Healthcare is recalling 19,032 bags of Cefazolin Injection due to the presence of particulate matter. The affected product is distributed nationwide in the US.

    Product
    CEFAZOLIN — CEFAZOLIN (CEFAZOLIN SODIUM)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0749-2026·2026-08-19

    Apollo Care Recalls Semaglutide Vials Due to Particulate Matter

    Apollo Care, LLC is recalling specific lots of Semaglutide 6.75mg vials because they contain nylon and silk-type particulate matter.

    Product
    SEMAGLUTIDE 6.75mg (4.5 mg/mL), 1.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202 NDC 71170-821-01
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0748-2026·2026-08-19

    Apollo Care Recalls Semaglutide Vials Due to Particulate Matter

    Apollo Care, LLC is recalling specific lots of Semaglutide 2.25mg vials because they contain nylon and silk-type particulate matter.

    Product
    SEMAGLUTIDE 2.25MG (0.9 mg/mL), 2.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202 NDC 71170-811-02
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0766-2026·2026-08-19

    Prestige Recalls Clear Eyes Maximum Itchy Eye Relief Due to Sterility Concerns

    Prestige Brands Holdings is recalling Clear Eyes Maximum Itchy Eye Relief eye drops due to a lack of assurance of sterility and potential contamination.

    Product
    CLEAR EYES MAXIMUM ITCHY EYE RELIEF — CLEAR EYES MAXIMUM ITCHY EYE RELIEF (GLYCERIN AND NAPHAZOLINE HYDROCHLORIDE AND ZINC SULFATE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0753-2026·2026-08-19

    Apollo Care Recalls Semaglutide Vials Due to Particulate Matter

    Apollo Care, LLC is recalling 250 vials of Semaglutide 2.5mg due to the presence of nylon and silk particulate matter.

    Product
    SEMAGLUTIDE 2.5mg (1mg/mL), Glycine 12.5 mg (5mg/mL), 2.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-711-02
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0750-2026·2026-08-19

    Apollo Care Recalls Semaglutide Vials Due to Particulate Matter

    Apollo Care, LLC is recalling 9,762 vials of Semaglutide 4.5mg due to the presence of nylon and silk-type particulate matter.

    Product
    SEMAGLUTIDE 4.5mg (0.9 mg/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-812-03
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0755-2026·2026-08-19

    Apollo Care Recalls Semaglutide Vials Due to Particulate Matter

    Apollo Care is recalling 250 vials of Semaglutide 7.5mg due to the presence of nylon and silk-type particulate matter.

    Product
    SEMAGLUTIDE 7.5mg (5mg/mL), Glycine 7.5 mg (5mg/mL), 1.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-721-01
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0756-2026·2026-08-19

    Apollo Care Recalls Semaglutide Vials Due to Particulate Matter

    Apollo Care, LLC is recalling 500 vials of Semaglutide 10mg due to the presence of nylon and silk-type particulate matter.

    Product
    SEMAGLUTIDE 10mg (5mg/mL), Glycine 10 mg (5mg/mL), 2 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-722-02
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0762-2026·2026-08-19

    Shoolin Pharma Recalls Tadalafil USP Due to CGMP Deviations

    Shoolin Pharma Chem LLP is recalling Tadalafil USP 1.00 KG bags due to Current Good Manufacturing Practice (CGMP) deviations noted during an FDA inspection.

    Product
    TADALAFIL USP, 1.00 KG, 1KG(1000gm)-bag, Rx only, "For Prescription Compounding Only", Shoolin Pharma Chem LLP, Block/Survey no 408, B/H Ratnamani Tubes, Near Maruti Inox, Indrad, Kadi, Mahesania, Gujarat, 382715, India, (CAS NO 171596-29-5), NDC 85702-001-08
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0752-2026·2026-08-19

    Apollo Care Recalls Semaglutide Vials Due to Particulate Matter

    Apollo Care, LLC is recalling 4,748 vials of Semaglutide 0.9mg due to the presence of nylon and silk particulate matter.

    Product
    SEMAGLUTIDE 0.9mg (0.9 mg/mL), 1 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-810-01
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0747-2026·2026-08-19

    Apollo Care Recalls Semaglutide Vials Due to Particulate Matter

    Apollo Care, LLC is recalling 56,918 vials of Semaglutide 12.5mg due to the presence of nylon and silk particulate matter.

    Product
    SEMAGLUTIDE 12.5MG (2.5MG/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-495-05
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0754-2026·2026-08-19

    Apollo Care Recalls Semaglutide Vials Due to Particulate Matter

    Apollo Care, LLC is recalling 250 vials of Semaglutide 5mg due to the presence of nylon and silk-type particulate matter.

    Product
    SEMAGLUTIDE 5mg (1mg/mL), Glycine 25 mg (5mg/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202.NDC 71170-712-03
    Category
    Drug
    Distribution
    Distributed nationwide
  • CriticalFDA (Drugs)·D-0743-2026·2026-08-12

    Cyclophosphamide Injection Recalled Due to Stainless Steel Particulate Matter

    Sunny Pharmtech Inc. is recalling 4,077 vials of Cyclophosphamide for Injection due to stainless steel particulate matter found in the product. The recall affects vials distributed nationwide in the USA.

    Product
    Cyclophosphamide for Injection, USP, 1 gram/vial, One Single-Dose Vial, Rx only, Manufactured for: Long Grove Pharmaceuticals, LLC, Rosemont, IL 60018. Manufactured in Taiwan, NDC 81298-8112-1
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0745-2026·2026-08-12

    FDA Recalls Mirabegron Tablets Over Nitrosamine Impurity

    Zydus Pharmaceuticals is recalling Mirabegron extended-release tablets, 25 mg, due to an out-of-specification result for the N-Nitroso Mirabegron impurity. The recall affects nationwide distribution in the USA.

    Product
    MIRABEGRON — MIRABEGRON (MIRABEGRON)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0744-2026·2026-08-12

    Cyclophosphamide Injection Recall: Stainless Steel Particulate Matter Found

    Cyclophosphamide for Injection, USP, 2 gram/vial, is being recalled due to the presence of particulate matter identified as stainless steel. The recall affects 1,464 vials distributed nationwide.

    Product
    Cyclophosphamide for Injection, USP, 2 gram/vial, One Single-Dose Vial, Rx only, Manufactured for: Long Grove Pharmaceuticals, LLC, Rosemont, IL 60018. Manufactured in Taiwan, NDC 81298-8114-1
    Category
    Drug
    Distribution
    Distributed nationwide
  • CriticalFDA (Drugs)·D-0732-2026·2026-07-29

    Cetirizine Hydrochloride Tablets Recalled Due to Cross Contamination with Ranitidine

    JB Chemicals and Pharmaceuticals Ltd is recalling 34,020 bottles of Cetirizine Hydrochloride Tablets USP 5 mg because some tablets were found to contain Ranitidine due to cross contamination.

    Product
    CETIRIZINE HYDROCHLORIDE — CETIRIZINE HYDROCHLORIDE (CETIRIZINE HYDROCHLORIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0715-2026·2026-07-29

    ROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns

    Rohto-Mentholatum (Vietnam) Co., Ltd. is recalling ROHTO Cooling Eye Drops due to a lack of assurance of sterility. The recall affects multiple lots distributed nationwide within the United States.

    Product
    Rohto Cooling Eye Drops ALL-IN-ONE (hypromellose 0.2%, tetrahydrozoline HCL 0.05%, zinc sulfate 0.25%), Sterile 0.4 FL OZ (13 mL), Distributed by: The Mentholatum Company, Orchard Park, NY 14127, Made in Vietnam UPC 310742010862, NDC 10742-8146-1
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0719-2026·2026-07-29

    ROHTO DIGI-EYE Eye Drops Recalled Over Sterility Assurance Gap

    Rohto Digi-Eye cooling eye drops are recalled due to a lack of assurance of sterility. The recall affects 65,219 cartons distributed nationwide in the U.S.

    Product
    ROHTO DIGI-EYE — ROHTO DIGI-EYE (HYPROMELLOSE, TETRAHYDROZOLINE HYDROCHLORIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0703-2026·2026-07-29

    Levothyroxine Sodium Tablets Recalled for Subpotency

    Major Pharmaceuticals is recalling Levothyroxine Sodium Tablets, 88 mcg, lot N02310, due to subpotency. The recall is voluntary and affects nationwide distribution in the USA.

    Product
    LEVOTHYROXINE SODIUM — LEVOTHYROXINE SODIUM (LEVOTHYROXINE SODIUM)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0702-2026·2026-07-29

    Major Pharmaceuticals Recalls Levothyroxine Sodium Tablets Over Subpotency

    Major Pharmaceuticals is voluntarily recalling Levothyroxine Sodium Tablets, 75 mcg, NDC 0904-6951-61, due to subpotency. The recall affects lots N02172, N02296, and N02288 with expiration dates in July and December 2026, distributed nationwide.

    Product
    LEVOTHYROXINE SODIUM — LEVOTHYROXINE SODIUM (LEVOTHYROXINE SODIUM)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0720-2026·2026-07-29

    FDA Recalls Rohto Dry-Aid Eye Drops Over Sterility Assurance Gap

    Rohto-Mentholatum is recalling 972,001 cartons of ROHTO DRY-AID sterile eye drops due to lack of assurance of sterility. The recall affects lots distributed nationwide in the U.S.

    Product
    Rohto Cooling Eye Drops Dry Aid (povidone 0.68%, propylene glycol 0.3%), Sterile, 0.34 FL OZ (10 mL), Distributed by: The Mentholatum Company, Orchard Park, NY 14127, Made in Vietnam, UPC 310742011135, NDC 10742-8162-1
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Food)·H-1178-2026·2026-07-29

    Dietary Supplement Modern Warrior Ready Recalled for Unapproved Ingredients

    Modern Warrior Life, LLC is recalling Modern Warrior Ready dietary supplements because they contain unapproved ingredients including tianeptine, 1,4 DMAA, and aniracetam.

    Product
    Modern Warrior Ready, Dietary Supplement, 60 CAPSULES
    Category
    Drug
    Distribution
    Distributed nationwide